Adagene Current Valuation vs. Market Capitalization

ADAG Stock  USD 2.45  0.03  1.24%   
Based on the measurements of profitability obtained from Adagene's financial statements, Adagene may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Adagene's ability to earn profits and add value for shareholders. The current Price To Sales Ratio is estimated to decrease to 4.43. The current Days Sales Outstanding is estimated to decrease to 4.25. At this time, Adagene's Total Other Income Expense Net is most likely to increase significantly in the upcoming years. The Adagene's current Income Tax Expense is estimated to increase to about 1.8 M, while Operating Income is projected to decrease to (28.6 M).
For Adagene profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Adagene to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Adagene utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Adagene's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Adagene over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.72)
Revenue Per Share
0.019
Quarterly Revenue Growth
(0.85)
Return On Assets
(0.20)
Return On Equity
(0.46)
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Adagene Market Capitalization vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Adagene's current stock value. Our valuation model uses many indicators to compare Adagene value to that of its competitors to determine the firm's financial worth.
Adagene is rated third in current valuation category among its peers. It is rated fifth in market capitalization category among its peers creating about  1.79  of Market Capitalization per Current Valuation. At this time, Adagene's Market Cap is most likely to decrease significantly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Adagene by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Adagene Current Valuation vs. Competition

Adagene is rated third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 1.71 Billion. Adagene holds roughly 60.7 Million in current valuation claiming about 4% of equities under Health Care industry.

Adagene Market Capitalization vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Adagene

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
60.7 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Adagene

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
108.46 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Adagene Market Capitalization vs Competition

Adagene is rated fifth in market capitalization category among its peers. Market capitalization of Health Care industry is presently estimated at about 3.86 Billion. Adagene holds roughly 108.46 Million in market capitalization claiming about 2.81% of equities under Health Care industry.
Capitalization  Total debt  Revenue  Workforce  Valuation

Adagene Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Adagene, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Adagene will eventually generate negative long term returns. The profitability progress is the general direction of Adagene's change in net profit over the period of time. It can combine multiple indicators of Adagene, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-1.8 M-1.7 M
Net Interest Income3.2 M3.3 M
Interest Income4.3 M4.5 M
Operating Income-27.2 M-28.6 M
Net Loss-18.9 M-19.9 M
Income Before Tax-17.3 M-18.1 M
Total Other Income Expense Net9.9 M10.4 M
Net Loss-65.9 M-62.6 M
Net Loss-18.9 M-19.9 M
Income Tax Expense1.7 M1.8 M
Change To Netincome22.2 M23.3 M
Net Loss(0.43)(0.45)
Income Quality 1.50  1.58 
Net Income Per E B T 1.10  0.82 

Adagene Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Adagene. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Adagene position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Adagene's important profitability drivers and their relationship over time.

Use Adagene in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adagene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will appreciate offsetting losses from the drop in the long position's value.

Adagene Pair Trading

Adagene Pair Trading Analysis

The ability to find closely correlated positions to Adagene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adagene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adagene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adagene to buy it.
The correlation of Adagene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adagene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adagene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adagene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Adagene position

In addition to having Adagene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Services Thematic Idea Now

Business Services
Business Services Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Services theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Services Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports:
Check out Trending Equities.
For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
To fully project Adagene's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Adagene at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Adagene's income statement, its balance sheet, and the statement of cash flows.
Potential Adagene investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Adagene investors may work on each financial statement separately, they are all related. The changes in Adagene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Adagene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.